Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (413584448, 390649896)
Deutsches Zentrum für Lungenforschung
Received: 25 April 2022
Accepted: 29 August 2022
First Online: 21 September 2022
: Patients consented to the use of their data via the German Center for Lung Research (<i>Deutsches Zentrum für Lungenforschung, DZL</i>) consent form. The project was reviewed and is covered under the University of Giessen ethics committee decision (AZ 58/15) and was performed according to the appropriate regulations and the Declaration of Helsinki.
: Not applicable.
: No competing interests related to this work. Dr. Seeger reports personal fees from Actelion, personal fees from Bayer AG, personal fees from Novartis, personal fees from Vectura, personal fees from Medspray, personal fees from United Therapeutics, outside the submitted work.